The BRCA1/2 Parent-of-Origin Effect on Breast Cancer Risk-Letter.
Department of Genomic Medicine, Division of Evolution and Genomic Science, MAHSC, Central Manchester NHS Foundation Trust, Manchester, United Kingdom. gareth.evans@cmft.nhs.uk.|Nightingale & Prevention Breast Cancer Centre, University Hospital of South Manchester, Manchester, United Kingdom.
D Gareth R
DG
Evans
Nightingale & Prevention Breast Cancer Centre, University Hospital of South Manchester, Manchester, United Kingdom.|Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, United Kingdom.
Elaine
E
Harkness
Department of Genomic Medicine, Division of Evolution and Genomic Science, MAHSC, Central Manchester NHS Foundation Trust, Manchester, United Kingdom.
Fiona
F
Lalloo
D019313:BRCA1 Protein / Q000235:genetics* / Q000378:metabolism; D024682:BRCA2 Protein / Q000235:genetics* / Q000378:metabolism; D001943:Breast Neoplasms / Q000235:genetics*; D005260:Female; D006801:Humans; D012307:Risk Factors
D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human